Hirohito Yamazaki

2.2k total citations
95 papers, 1.4k citations indexed

About

Hirohito Yamazaki is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Hirohito Yamazaki has authored 95 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hematology, 39 papers in Immunology and 24 papers in Oncology. Recurrent topics in Hirohito Yamazaki's work include Hematopoietic Stem Cell Transplantation (67 papers), Immune Cell Function and Interaction (21 papers) and T-cell and B-cell Immunology (18 papers). Hirohito Yamazaki is often cited by papers focused on Hematopoietic Stem Cell Transplantation (67 papers), Immune Cell Function and Interaction (21 papers) and T-cell and B-cell Immunology (18 papers). Hirohito Yamazaki collaborates with scholars based in Japan, United States and Sweden. Hirohito Yamazaki's co-authors include Shinji Nakao, Akiyoshi Takami, Chiharu Sugimori, Tatsuya Chuhjo, Yukio Kondo, Mitsuhiro Omine, Hideaki Mizoguchi, Xingmin Feng, Masanao Teramura and Naomi Sugimori and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Hirohito Yamazaki

90 papers receiving 1.4k citations

Peers

Countries citing papers authored by Hirohito Yamazaki

Since Specialization

Citations

This map shows the geographic impact of Hirohito Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirohito Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirohito Yamazaki more than expected).

Fields of papers citing papers by Hirohito Yamazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirohito Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirohito Yamazaki. The network helps show where Hirohito Yamazaki may publish in the future.

Co-authorship network of co-authors of Hirohito Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hirohito Yamazaki. A scholar is included among the top collaborators of Hirohito Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirohito Yamazaki. Hirohito Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia 2025 ·Blood Advances ·Jong Wook Lee, Jun Ho Jang, Hirohito Yamazaki, (unknown), (unknown), Yoshiaki Tomiyama, Koji Nagafuji, Kensuke Usuki, Jyh‐Pyng Gau, Yasuyoshi Morita, Jih‐Luh Tang, Hung Chang, (unknown), Akira Matsuda, Keiya Ozawa, Kinuko Mitani, Yoshinobu Kanda, Shinji Nakao	1
2	HLA Class I Allele-Deficient Clones Regenerate in Immune Aplastic Anemia without Anti-Thymocyte Globulin 2024 ·Blood ·Yoshitaka Zaimoku, Kazuyoshi Hosomichi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroyuki Maruyama, Kohei Hosokawa, Hiroyuki Takamatsu, Hirohito Yamazaki, Kazuya Sakai, Ishikazu Mizuno, Toshihiro Miyamoto, Shinji Nakao	0
3	Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia 2023 ·Transplantation and Cellular Therapy ·Yasushi Onishi, Takehiko Mori, Hirohito Yamazaki, Nobuhiro Hiramoto, Yoshitaka Zaimoku, Minoru Kanaya, Kosei Matsue, Makoto Onizuka, Nobuyuki Aotsuka, Naoyuki Uchida, Koichi Onodera, Junya Kanda, Hirohisa Nakamae, (unknown), Takuro Kuriyama, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta	2
4	Familial immune‐mediated aplastic anaemia in six different families 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Kazuyoshi Hosomichi, Yasuhito Nannya, Yoshitaka Zaimoku, (unknown), Takamasa Katagiri, Ken Ishiyama, Hirohito Yamazaki, Ryosuke Ogawa, Mika Kuroiwa, Atsushi Tajima, Seishi Ogawa, Shinji Nakao	3
5	Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15 2022 ·Leukemia ·(unknown), Kohei Hosokawa, (unknown), (unknown), Yoshitaka Zaimoku, Takamasa Katagiri, Tatsuhiko Ozawa, Hiroyuki Takamatsu, Ken Ishiyama, Hirohito Yamazaki, Hiroyuki Kishi, Seishi Ogawa, Shinji Nakao	2
6	HLA class I allele–lacking leukocytes predict rare clonal evolution to MDS/AML in patients with acquired aplastic anemia 2021 ·Blood ·Kohei Hosokawa, (unknown), (unknown), Hiroyuki Maruyama, (unknown), (unknown), (unknown), (unknown), Yoshitaka Zaimoku, Mai Ánh Nguyễn, (unknown), Ken Ishiyama, Hirohito Yamazaki, Takamasa Katagiri, Hiroyuki Takamatsu, Kazuyoshi Hosomichi, Atsushi Tajima, Fumihiro Azuma, Seishi Ogawa, Shinji Nakao	12
7	Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia 2021 ·Leukemia ·(unknown), Kohei Hosokawa, (unknown), (unknown), Takamasa Katagiri, Ken Ishiyama, Hirohito Yamazaki, Fumihiro Azuma, Yasuhito Nanya, Seishi Ogawa, Shinji Nakao	5
8	The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β 2021 ·Leukemia ·(unknown), Kohei Hosokawa, Mai Ánh Nguyễn, (unknown), (unknown), (unknown), (unknown), Luis Espinoza, Mahmoud El‐Badry, Md Mohiuddin, Takamasa Katagiri, Masanori Ono, Hiroshi Fujiwara, Kazuhisa Chonabayashi, Yoshinori Yoshida, Hirohito Yamazaki, Atsushi Hirao, Shinji Nakao	12
9	Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt) 2019 ·International Journal of Hematology ·Koji Nagafuji, Itaru Matsumura, Takayuki Shimose, Tatsuya Kawaguchi, Junya Kuroda, Hirohisa Nakamae, Toshihiro Miyamoto, Norimitsu Kadowaki, Jun Ishikawa, Yutaka Imamura, Hirohito Yamazaki, Koichi Akashi, Yuzuru Kanakura	22
10	Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia 2017 ·Biology of Blood and Marrow Transplantation ·Yasushi Onishi, Takehiko Mori, Shinichi Kako, Hideo Koh, Naoyuki Uchida, Tadakazu Kondo, Takeshi Kobayashi, Hiromasa Yabe, Toshihiro Miyamoto, Koji Kato, Ritsuro Suzuki, Shinji Nakao, Hirohito Yamazaki	15
11	Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia 2016 ·Annals of Hematology ·(unknown), Hirohito Yamazaki, Hiroyuki Takamatsu, Chiharu Sugimori, Takamasa Katagiri, Hiroyuki Maruyama, Yoshitaka Zaimoku, (unknown), (unknown), J. Luis Espinoza, Shinji Nakao	20
12	Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia 2016 ·Experimental Hematology ·Hiroyuki Maruyama, Takamasa Katagiri, Koichi Kashiwase, Takashi Shiina, Aiko Sato‐Otsubo, Yoshitaka Zaimoku, (unknown), Kohei Hosokawa, Ken Ishiyama, Hirohito Yamazaki, Hidetoshi Inoko, Seishi Ogawa, Shinji Nakao	20
13	Border between aplastic anemia and myelodysplastic syndrome 2013 ·International Journal of Hematology ·Hirohito Yamazaki, Shinji Nakao	12
14	Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study 2011 ·Annals of Hematology ·Masaki Yamaguchi, Toshiro Kurokawa, Ken Ishiyama, (unknown), Mikio Ueda, Sadaya Matano, Akiyoshi Takami, Hirohito Yamazaki, (unknown), (unknown), Takashi Yoshida, Shinji Nakao	24
15	An Epstein-Barr Virus-Associated Leukemic Lymphoma in a Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine for Hepatitis-Associated Aplastic Anemia 2011 ·Acta Haematologica ·(unknown), Noriko Iwaki, (unknown), Yukio Kondo, Hirohito Yamazaki, Shinji Nakao	6
16	Leuconostoc bacteremia in three patients with malignancies 2010 ·Journal of Infection and Chemotherapy ·(unknown), (unknown), Hirohito Yamazaki, Shinji Nakao, (unknown), Ken Ishiyama, Yasuko Senda, (unknown)	9
17	Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia 2010 ·Annals of Hematology ·(unknown), Hiroyuki Takamatsu, J. Luis Espinoza, Xuzhang Lu, Naomi Sugimori, Hirohito Yamazaki, Katsuya Okawa, Shinji Nakao	17
18	Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections 2008 ·International Journal of Hematology ·Takeshi Yamashita, Chiharu Sugimori, Ken Ishiyama, Hirohito Yamazaki, Hirokazu Okumura, Yukio Kondo, Akiyoshi Takami, Shinji Nakao	5
19	A Case of Acute Cutaneous Graft-versus-Host Disease Mimicking Psoriasis Vulgaris 2007 ·Dermatology ·Takashi Matsushita, Minoru Hasegawa, Fumiaki Shirasaki, Manabu Fujimoto, Hirohito Yamazaki, Shinichi Sato, Kazuhiko Takehara	19
20	Cyclosporine Therapy for Acquired Aplastic Anemia: Predictive Factors for the Response and Long-term Prognosis 2007 ·International Journal of Hematology ·Hirohito Yamazaki, Chiharu Sugimori, Tatsuya Chuhjo, Shinji Nakao	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact